Sotabase

Career

· PhD Student, Stanford University2022–
· Software Engineer, Google Research2018–2022
· Undergraduate Student, University of Illinois at Urbana-Champaign2014–2018
· Senior Applied Science Manager, Amazon
· Chief Data and AI Officer, CareDx, Inc.
· B.A. in Statistics and Probability, Peking University
· Research Assistant, Stanford Artificial Intelligence Laboratory (SAIL)
· LSRA, Stanford Blood Center
· M.S. in Epidemiology, Stanford University
· Ph.D. in Statistics, Stanford University
· Stanford Executive Program, Stanford University Graduate School of Business
· SVP of Bioinformatics & Data Science, Veracyte, Inc.

Publications (171)

On the Opportunities and Risks of Foundation Models
arXiv.org · 2021
5,795
cited
Image indexing using color correlograms
Proceedings of IEEE Computer Society Conference on Computer Vision and Pattern Recognition · 1997
1,982
cited
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
Journal of the American Medical Association (JAMA) · 2021
576
cited
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
The Lancet Oncology · 2020
446
cited
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
Nature Medicine · 2023
410
cited
Spatial Color Indexing and Applications
Sixth International Conference on Computer Vision (IEEE Cat. No.98CH36271) · 1998
381
cited
Use of RNAi technology to develop a PRSV-resistant transgenic papaya
Scientific Reports · 2017
363
cited
Document-Level Relation Extraction with Adaptive Thresholding and Localized Context Pooling
AAAI Conference on Artificial Intelligence · 2020
341
cited
Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer
Clinical Cancer Research · 2013
239
cited
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
Clinical Cancer Research · 2018
179
cited
Multi-hop Attention Graph Neural Networks
International Joint Conference on Artificial Intelligence · 2020
161
cited
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
British Journal of Cancer · 2018
133
cited
An automatic hierarchical image classification scheme
MULTIMEDIA '98 · 1998
126
cited
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial
Nature Medicine · 2023
123
cited
AxBench: Steering LLMs? Even Simple Baselines Outperform Sparse Autoencoders
International Conference on Machine Learning · 2025
114
cited
Causal Abstraction: A Theoretical Foundation for Mechanistic Interpretability
2023
114
cited
Crosstalk between Spinal Astrocytes and Neurons in Nerve Injury-Induced Neuropathic Pain
PLoS ONE · 2009
105
cited
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
Cancer Communications · 2020
94
cited
Improving Graph Attention Networks with Large Margin-based Constraints
arXiv.org · 2019
92
cited
MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.
Journal of the American Society of Nephrology · 2017
91
cited
Sotabase